Filing Details
- Accession Number:
- 0001127602-14-012478
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-21 16:17:51
- Reporting Period:
- 2014-03-20
- Filing Date:
- 2014-03-21
- Accepted Time:
- 2014-03-21 16:17:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1181174 | Caroline Dorsa | Biogen Idec Inc. 225 Binney Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-20 | 10,000 | $53.64 | 24,468 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-20 | 2,200 | $347.28 | 22,268 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-20 | 2,701 | $348.66 | 19,567 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-20 | 4,199 | $349.54 | 15,368 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-20 | 900 | $350.37 | 14,468 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-03-20 | 10,000 | $0.00 | 10,000 | $53.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2020-01-03 | No | 4 | M | Direct |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934
- This represents the weighted average price for shares purchased at a range between $347.06 (low) and $347.95 (high).
- Full information regarding the number of shares purchased at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- This represents the weighted average price for shares purchased at a range between $348.09 (low) and $349.06 (high).
- This represents the weighted average price for shares purchased at a range between $349.11 (low) and $350.08 (high).
- This represents the weighted average price for shares purchased at a range between $350.11 (low) and $350.85 (high).
- The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 01/04/2010.
Billionaire Hedge Funds
